Serum interleukin-37 (IL-37) and its gene polymorphism in Iranian Behcet's disease patients: Association with disease manifestations and activity-Reference-Cited by-同舟云学术

Serum interleukin-37 (IL-37) and its gene polymorphism in Iranian Behcet's disease patients: Association with disease manifestations and activity

Published:2020-12 Issue: Volume:26 Page:100794
ISSN:2214-5400
Container-title:Meta Gene
language:en
Short-container-title:Meta Gene

Author:

Gholijani Nasser,Daryabor Gholamreza,Yazdani Mohammad Reza,Vazani Negin,Shabbooei Bahareh,Zahed Maryam,Ranjbar Mohammad Ali,Sadeghi Mohammad Bagher,Amirghofran Zahra^ORCID

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference38 articles.

1. Interleukin-37 expression is decreased in Behcet’s disease and is associated with inflammation;Bouali;Immunol. Lett.,2015

2. Suppression of inflammation and acquired immunity by IL-37;Cavalli;Immunol. Rev.,2018

3. Behcet’s disease: epidemiology, clinical manifestations, and diagnosis;Davatchi;Expert. Rev. Clin. Immunol.,2017

4. Suppression of innate inflammation and immunity by interleukin-37;Dinarello;Eur. J. Immunol.,2016

5. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica;Farrokhi;Acta Neurol. Belg.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade;International Journal of Molecular Sciences;2023-11-16

2. The skin in Behçet's disease: Mucocutaneous findings and differential diagnosis;JEADV Clinical Practice;2022-02-14

3. Interleukin-27 gene variant rs153109 is associated with enhanced cytokine serum levels and susceptibility to Behçet's disease in the Iranian population;European Cytokine Network;2020-12